tiprankstipranks
Trending News
More News >
PharmaSGP Holding SE (DE:PSG)
:PSG
Germany Market

PharmaSGP Holding SE (PSG) Income Statement

Compare
5 Followers

PharmaSGP Holding SE Income Statement

Last quarter (Q3 2024), PharmaSGP Holding SE's total revenue was €30.21M, an increase of 16.34% from the same quarter last year. In Q3, PharmaSGP Holding SE's net income was €5.37M. See PharmaSGP Holding SE’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
€ 101.10M€ 85.82M€ 65.34M€ 63.25M€ 62.57M
Gross Profit
€ 91.64M€ 76.79M€ 58.86M€ 57.04M€ 56.71M
Operating Expenses
€ 67.00M€ 59.11M€ 43.36M€ 40.97M€ 32.22M
Depreciation and Amortization
€ 9.37M€ 9.19M€ 3.57M€ 486.00K€ 397.00K
EBITDA
€ 35.87M€ 27.18M€ 18.49M€ 14.74M€ 22.84M
Operating Income
€ 24.64M€ 17.60M€ 15.42M€ 16.05M€ 24.40M
Other Income/Expenses
€ -2.75M€ -3.24M€ -1.46M€ -735.00K€ -4.58M
Pretax Income
€ 21.89M€ 15.80M€ 14.21M€ 14.15M€ 22.26M
Net Income
€ 16.40M€ 11.95M€ 10.69M€ 10.64M€ 16.71M
Per Share Metrics
Basic EPS
€ 1.37€ 1.00€ 0.89€ 0.89€ 1.39
Diluted EPS
€ 1.37€ 1.00€ 0.89€ 0.89€ 1.39
Weighted Average Shares Outstanding
11.99M 12.00M 12.00M 12.00M 12.00M
Weighted Average Shares Outstanding (Diluted)
11.99M 12.00M 12.00M 12.00M 12.00M
Currency in EUR

PharmaSGP Holding SE Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis